Clyde Markowitz

5.6k total citations · 1 hit paper
59 papers, 2.7k citations indexed

About

Clyde Markowitz is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology. According to data from OpenAlex, Clyde Markowitz has authored 59 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pathology and Forensic Medicine, 13 papers in Rheumatology and 12 papers in Neurology. Recurrent topics in Clyde Markowitz's work include Multiple Sclerosis Research Studies (39 papers), Peripheral Neuropathies and Disorders (9 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Clyde Markowitz is often cited by papers focused on Multiple Sclerosis Research Studies (39 papers), Peripheral Neuropathies and Disorders (9 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Clyde Markowitz collaborates with scholars based in United States, Canada and Switzerland. Clyde Markowitz's co-authors include Steven Galetta, Dina Jacobs, Laura J. Balcer, Elliot M. Frohman, Teresa C. Frohman, Monika Baier, Peter A. Calabresi, Maureen G. Maguire, Heather Winslow and Nicholas J. Volpe and has published in prestigious journals such as NeuroImage, Neurology and Annals of Neurology.

In The Last Decade

Clyde Markowitz

58 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Relation of Visual Function to Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis

2006 492 citations Dina Jacobs, Clyde Markowitz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Clyde Markowitz United States	25	1.6k	918	531	464	394	59	2.7k
Jan Dörr Germany	36	1.8k 1.1×	1.0k 1.1×	631 1.2×	432 0.9×	316 0.8×	76	3.3k
Paulus Rommer Austria	34	2.4k 1.5×	194 0.2×	1.7k 3.2×	664 1.4×	462 1.2×	172	3.7k
Anja Eckstein Germany	32	2.6k 1.6×	1.3k 1.4×	603 1.1×	205 0.4×	248 0.6×	147	4.4k
Ángela Vidal‐Jordana Spain	22	1.7k 1.0×	103 0.1×	630 1.2×	473 1.0×	232 0.6×	76	2.3k
Dejan Jakimovski United States	29	2.1k 1.3×	95 0.1×	764 1.4×	511 1.1×	288 0.7×	179	3.0k
Carol M. Brownscheidle United States	15	1.6k 1.0×	154 0.2×	759 1.4×	549 1.2×	203 0.5×	24	2.1k
Carmen Tur Spain	31	2.7k 1.6×	119 0.1×	1.2k 2.3×	751 1.6×	154 0.4×	109	3.6k
Ilya Kister United States	33	2.0k 1.2×	115 0.1×	981 1.8×	382 0.8×	268 0.7×	110	2.7k
Darin T. Okuda United States	24	2.7k 1.6×	90 0.1×	1.1k 2.1×	650 1.4×	328 0.8×	113	3.4k
Nicolas Collongues France	28	2.0k 1.2×	174 0.2×	1.6k 3.1×	523 1.1×	265 0.7×	105	2.7k

Countries citing papers authored by Clyde Markowitz

Since Specialization

Citations

This map shows the geographic impact of Clyde Markowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clyde Markowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clyde Markowitz more than expected).

Fields of papers citing papers by Clyde Markowitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clyde Markowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clyde Markowitz. The network helps show where Clyde Markowitz may publish in the future.

Co-authorship network of co-authors of Clyde Markowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Clyde Markowitz. A scholar is included among the top collaborators of Clyde Markowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clyde Markowitz. Clyde Markowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Orthmann‐Murphy, Jennifer, et al.. (2025). Beyond relapses: How BTK inhibitors are shaping the future of progressive MS treatment. Neurotherapeutics. 22(4). e00602–e00602. 1 indexed citations

Schindler, Matthew K., Amit Bar‐Or, Rachel Brandstadter, et al.. (2025). Investigating mood and cognition in people with multiple sclerosis: a prospective cross-sectional study protocol. BMJ Open. 15(5). e094733–e094733.

Markowitz, Clyde, et al.. (2024). A Proposed Approach to Screening and Surveillance Labs for Patients With Multiple Sclerosis on Anti-CD20 Therapy. Neurology Clinical Practice. 14(1). e200241–e200241. 2 indexed citations

Coyle, Patricia K., Mark S. Freedman, Bruce A. Cohen, Bruce Cree, & Clyde Markowitz. (2024). Sphingosine 1‐phosphate receptor modulators in multiple sclerosis treatment: A practical review. Annals of Clinical and Translational Neurology. 11(4). 842–855. 23 indexed citations

O’Donnell, Carly M., Mark A. Elliott, Shahamat Tauhid, et al.. (2023). Intersite brain MRI volumetric biases persist even in a harmonized multisubject study of multiple sclerosis. Journal of Neuroimaging. 33(6). 941–952. 6 indexed citations

Thebault, Simon, Leah Zuroff, Matthew K. Schindler, et al.. (2023). Severe Neuroinvasive West Nile Virus in Association With Anti-CD20 Monotherapy for Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 10(5). 8 indexed citations

Baller, Erica B., Elizabeth Sweeney, Matthew Cieslak, et al.. (2023). Mapping the Relationship of White Matter Lesions to Depression in Multiple Sclerosis. Biological Psychiatry. 95(12). 1072–1080. 12 indexed citations

Berger, Joseph R., Clyde Markowitz, Peter A. Merkel, Rachel Kolster, & Zissimos P. Mourelatos. (2021). Multifocal neutrophilic meningoencephalitis: a novel disorder responsive to anakinra. Journal of Neurology. 268(8). 2995–2999. 1 indexed citations

Harvey, Denise Y., et al.. (2018). Uncovering the association between fatigue and fatigability in multiple sclerosis using cognitive control. Multiple Sclerosis and Related Disorders. 27. 269–275. 22 indexed citations

10.

Chahin, Salim, Deborah Miller, James Wilson, et al.. (2015). Relation of quantitative visual and neurologic outcomes to fatigue in multiple sclerosis. Multiple Sclerosis and Related Disorders. 4(4). 304–310. 17 indexed citations

11.

Markowitz, Clyde. (2015). Identifying and Addressing Unmet Therapeutic Needs in MS. The Journal of Clinical Psychiatry. 76(3). e08–e08. 4 indexed citations

12.

Coyle, Patricia K., Bruce A. Cohen, Thomas Leist, et al.. (2014). Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes. BMC Neurology. 14(1). 49–49. 10 indexed citations

13.

Leist, Thomas, Samuel F. Hunter, Daniel Kantor, & Clyde Markowitz. (2014). Novel Therapeutics in Multiple Sclerosis Management: Clinical Applications. The American Journal of Medicine. 127(1). S2–S2. 4 indexed citations

14.

Markowitz, Clyde. (2013). Multiple sclerosis update.. PubMed. 19(16 Suppl). s294–300. 29 indexed citations

15.

Bilello, Michel, Jarosław Krejza, John Woo, et al.. (2010). An Approach to Comparing Accuracies of Two Flair MR Sequences in the Detection of Multiple Sclerosis Lesions in the Brain in the Absence of Gold Standard. Academic Radiology. 17(6). 686–695. 7 indexed citations

16.

Jeffery, Douglas, et al.. (2010). Fingolimod for the treatment of relapsing multiple sclerosis. Expert Review of Neurotherapeutics. 11(2). 165–183. 30 indexed citations

17.

Mowry, Ellen M., Michael J. Loguidice, Anthony B. Daniels, et al.. (2009). Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity. Journal of Neurology Neurosurgery & Psychiatry. 80(7). 767–772. 95 indexed citations

18.

Markowitz, Clyde, Sergei Spitsin, Vanessa Zimmerman, et al.. (2009). The Treatment of Multiple Sclerosis with Inosine. The Journal of Alternative and Complementary Medicine. 15(6). 619–625. 80 indexed citations

19.

Burkholder, Bryn M., Benjamin Osborne, Michael J. Loguidice, et al.. (2009). Macular Volume Determined by Optical Coherence Tomography as a Measure of Neuronal Loss in Multiple Sclerosis. Archives of Neurology. 66(11). 1366–72. 148 indexed citations

20.

Gonen, Oded, Belinda S.Y. Li, James S. Babb, et al.. (2002). Relapsing-remitting Multiple Sclerosis and Whole-BrainN-Acetylaspartate Measurement: Evidence for Different Clinical Cohorts—Initial Observations. Radiology. 225(1). 261–268. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact